Skip to main content
. 2022 Nov 27;10(1):673–684. doi: 10.1002/ehf2.14245

Figure 5.

Figure 5

Predictors of cardiovascular and non‐cardiovascular mortality. (A) Predictors of CVD in non‐HFpEF. (B) Predictors of CVD in HFpEF. (C) Predictors of non‐CVD in non‐HFpEF. (D) Predictors of non‐CVD in HFpEF. Covariates: (i) CVD: age, sex, LVEF, NT‐proBNP level at admission, HF readmission, the NYHA functional class at discharge, and levels of SBP, haemoglobin, eGFR, and GNRI at discharge. When analysing patients with non‐HFpEF, we also added the prescription of ACE‐inhibitors/ARBs and β‐blockers at discharge as covariates in the model. (ii) Non‐CVD: age, sex, COPD, HF readmission, and levels of haemoglobin, eGFR, and GNRI at discharge.